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 Endoplasmic reticulum (ER) stress is caused by a num-
ber of biochemical and physiological stimuli that result in the
accumulation of unfolded proteins in the ER lumen, and it is
closely associated with the neuronal cell injury caused by vas-
cular and neurodegenerative diseases such as stroke, Alzheimer
disease, and Parkinson disease [1-3]. However, little is known
about the role, if any, of ER stress in retinal damage.
Retinal ganglion cell (RGC) death is a common feature
of many ophthalmic disorders such as glaucoma, optic neuro-
pathies, and retinovascular diseases, such as diabetic retin-
opathy and retinal vein occlusions. RGC death has been re-
ported to occur via a variety of mechanisms involving, for
example, oxidative stress [4], excitatory amino acids [5], ni-
tric oxide (NO) [6], and apoptosis [7]. Glutamate, one of the
excitatory amino acids, is the main neurotransmitter in the
retinal signaling pathway. Excessive glutamate increases both
intracellular Ca2+ and NO production through activation of the
N-methyl-D-aspartate (NMDA)-type glutamate receptor, re-
sulting in retinal cell death [8,9]. Recently, Uehara et al. [10]
reported that in primary cortical culture, even mild exposure
of NMDA induces apoptotic cell death. They demonstrated to
be caused by an accumulation of polyubiquitinated proteins
and increases in X box binding protein (XBP-1) mRNA splic-
ing and C/EBP-homologous (CHOP) mRNA, representing
activation of the unfolded-protein response (UPR) signaling
pathway. They also found that protein-disulphide isomerase
(PDI), which assists in the maturation and transport of un-
folded secretory proteins, prevented the neurotoxicity associ-
ated with ER stress. They suggest that neurodegenerative dis-
orders might be mediated by S-nitrosylation of PDI, which
would reduce its enzymatic activity. Their results strongly
suggest that activation of ER stress may participate in the reti-
nal cell death occurring after NMDA receptor activation and/
or ischemic insult. Hence, the purpose of the present study is
to examine how ER stress might induce retinal damage both
in vitro using cultured retinal ganglion cells (RGC-5, a rat
ganglion cell line transformed using E1A virus) and in vivo
(using ER stress-activated indicator (ERAI) transgenic mice,
in which effective identification of cells under ER-stress con-
ditions is possible in vivo, as described in our previous report)
[11]. Use of ERAI mice should provide valuable information
regarding the dynamics of ER stress-induced retinal damage.
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Purpose: To clarify whether endoplasmic reticulum (ER) stress is involved in retinal cell death, using cultured retinal
ganglion cells (RGC-5, a rat ganglion cell line transformed with E1A virus), and transgenic mice ER stress-activated
indicator (ERAI) mice carrying a human XBP1 and venus a variant of green fluorescent protein (GFP) fusion gene.
Methods: RGC-5 damage was induced by tunicamycin, and cell viability was measured by double nuclear staining
(Hoechst 33342 and either YO-PRO-1 or propidium iodide). The expressions of glucose-regulated protein 78(GRP78)/
BiP, the phosphorylated form of eukaryotic initiation factor 2α (p-eIF2α), and C/EBP-homologous (CHOP) protein after
tunicamycin (in vitro or in vivo) or N-methyl-D-aspartate (NMDA; in vivo) treatment were measured using immunoblot
or immunostaining. ERAI mice carrying the F-XBP1-DBD-venus expression gene were used to monitor ER-stress in
vivo. Twenty-four hours after intravitreal injection of tunicamycin or NMDA, or after raising intraocular pressure (IOP),
the retinal fluorescence intensity was visualized in anesthetized animals using an ophthalmoscope and in retinal flatmount
or cross-section specimens using laser confocal microscopy.
Results: Treatment with tunicamycin induced apoptotic cell death in RGC-5 and also induced production of ER stress-
related proteins (BiP, the phosphorylated form of eIF2α, and CHOP protein). In vivo, tunicamycin induced retinal gan-
glion cell (RGC) loss and thinning of the inner plexiform layer, 7 days after intravitreal injection. In flatmounted retinas of
ERAI mice, the fluorescence intensity arising from the XBP-1-venus fusion protein, indicating ER-stress activation, was
increased at 24 h after tunicamycin, NMDA, or IOP elevation. In transverse cross-sections from ERAI mice, the fluores-
cence intensity was first increased in cells of the ganglion cell and inner plexiform layers at 12 and 24 h, respectively, after
NMDA injection, and it was localized to ganglion and amacrine cells at 12 and 24 h, respectively, and to microglial cells
at 72 h. BiP and CHOP were increased at 12 h after NMDA injection, and the increases persisted for the remainder of the
72 h observation period.
Conclusions: These data indicate that ER-stress may play a pivotal role in RGC death, whether induced by NMDA or IOP
elevation.
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METHODS
Materials:  Dulbeco’s modified Eagles’s medium (D-MEM)
was purchased from Sigma-Aldrich (St. Louis, MO). The drugs
used and their sources were as follows. Tunicamycin was ob-
tained from Calbiochem (San Diego, CA) and Wako (Osaka,
Japan). Isoflurane was acquired from Nissan Kagaku (Tokyo,
Japan), and fetal bovine serum (FBS) was obtained from
Valeant (Costa Mesa, CA).
Retinal ganglion cell line (retinal ganglion cell-5) cul-
ture:  Cultures of RGC-5 were maintained in D-MEM supple-
mented with 10% FBS, 100 U/ml penicillin (Meiji Seika
Kaisha, Ltd., Tokyo, Japan), and 100 µg/ml streptomycin
(Meiji Seika Kaisha, Ltd.) in a humidified atmosphere of 95%
air and 5% CO2 at 37 °C. The RGC-5 cells were passaged by
trypsinization every 3 days, as in a previous report [12].
Cell viability assay after tunicamycin:  RGC-5 cells were
plated at a density of 1000 cells/well in 96-well culture plates
(number 3072, Falcon®, Becton Dickinson and Company,
Franklin Lakes, NJ). Twenty-four h later, cells were washed
twice with D-MEM and then immersed in D-MEM supple-
mented with 1% FBS plus tunicamycin at 1 to 4 µg/ml. Twenty-
four or forty-eight hours after the addition of tunicamycin,
cell viability was measured using a single-cell digital imag-
ing-based method employing fluorescent staining of nuclei.
Briefly, cell death was assessed on the basis of combination
staining with fluorescent dyes [namely, Hoechst 33342 (Mo-
lecular Probes, Eugene, OR) and either YO-PRO-1 (Molecu-
lar probes) or propidium iodide (PI; Molecular probes)]. Ob-
servations were made using an Olympus IX70 inverted
epifluorescence microscope (Olympus, Tokyo, Japan). At the
end of the above culture period, Hoechst 33342 and YO-PRO-
1 or PI dyes were added to the culture medium at 8 µM, 0.1
µM, and 1.5 µM, respectively, for 30 min. Images were col-
lected using a digital camera (Coolpix 4500, Nikon Corp.,
Tokyo, Japan). In a blind manner, a total of at least 400 cells
per condition were counted using image-processing software
(Image-J ver. 1.33f, National Institutes of Health, Bethesda,
MD). Cell mortality was quantified by expressing the number
of YO-PRO-1- or PI-positive cells as a percentage of the num-
ber of Hoechst 33342-positive cells.
Animals:  ER-stress-activated indicator (ERAI)-transgenic
mice carrying the F-XBP1DDBD-venus expression gene [11]
and their background wild-type mice (C57BL/6) aged 8-11
weeks or male adult ddY mice (Japan SLC, Hamamatsu, Ja-
pan) weighing 36-43 g for experiments other than the com-
parison with ERAI-transgenic mice were used, and were kept
under controlled lighting conditions (12 h:12 h light/dark).
All experiments were performed in accordance with the ARVO
statement for the Use of Animals in Ophthalmic and Vision
Research, and were approved and monitored by the Institu-
tional Animal Care and Use Committee of Gifu Pharmaceuti-
cal University.
Retinal damage induced by N-methyl-D-aspartate
(NMDA)-, tunicamycin-, or intraocular pressure (IOP) eleva-
tion: Male mice were anesthetized with 3.0% isoflurane and
maintained using 1.5% isoflurane in 70% N2O and 30% O2,
delivered via an animal general anesthesia machine (Soft
Lander, Sin-ei industry Co. Ltd., Saitama, Japan). The body
temperature was maintained at 37.0 - 37.5 °C with the aid of a
heating pad and heating lamp. Retinal damage was induced
by injection (2 µl/eye) either of NMDA (Sigma-Aldrich) at
20 mM dissolved in 0.01 M phosphate-buffered saline (PBS)
or of tunicamycin at 50 and 500 µg/ml, or (b) by acutely in-
creasing the intraocular pressure (IOP). For NMDA- or
tunicamycin-induced injury, the relevant agent was injected
into the vitreous body of the left eye under the above anesthe-
sia. In the IOP elevation model, the pupils were dilated with
topical 2.5% phenylephrine hydrochloride and 1% tropicamide
(Santen Pharmaceuticals Co. Ltd., Osaka, Japan). After topi-
cal instillation of 0.4% oxybuprocaine hydrochloride (Santen
Pharmaceuticals Co. Ltd.), the anterior chamber was cannu-
lated with a 32-gauge needle connected to a reservoir contain-
ing 0.9% NaCl. IOP was elevated by raising the height of the
reservoir, maintaining a pressure of 100 mm Hg for 45 min.
Retinal ischemia was confirmed by the blanching of the iris
and retinal circulation. At the end of the elevated IOP period,
the needle was removed, and reperfusion of the retinal vascu-
lature was confirmed by ophthalmoscopic examination (KOM
300; Konan Inc., Nishinomiya, Japan). One drop of
levofloxacin ophthalmic solution (Santen Pharmaceuticals Co.
Ltd.) was applied topically to the treated eye after each proce-
dure (intravitreal injection or ischemia-reperfusion).
Monitoring endoplasmic reticulum (ER) stress using
ERAI-transgenic mice:  In anesthetized ERAI-transgenic or
wild-type mice, retinal damage was induced by injection (2
µl/eye) of either NMDA at 20 mM or tunicamycin at 50 µg/
ml into the vitreous body, or by elevating IOP to 100 mmHg
for 45 min (see above). Twenty-four hours later, the fluores-
cence intensity arising from the XBP-1-venus fusion protein,
which is translated from the F-XBP1DDBD-venus gene, was
visualized in the retina of anesthetized animals using an oph-
thalmoscope (TRC-50; TOPCON, Tokyo, Japan) fitted with a
fluorescence filter. In separate experiments, the distribution
and time-course of changes in fluorescence intensity in the
retina were measured in retinal flatmount and cross-section
specimens using either laser confocal microscopy (Bio-Lad
Laboratories, Inc, Hercules, CA) or epifluorescence micros-
copy (Power BX50; Olympus, Tokyo, Japan). At various times
after the intravitreal injections (12, 24, and 72 h), eyes were
enucleated, then fixed in 4% paraformaldehyde for 1 h or over-
night at 4 °C as preparation for retinal flatmount and retinal
cross-section, respectively. For the preparation of retinal
flatmounts, detached retinas were flatmounted on slides (MAS
COAT; MATSUNAMI GLASS IND., LTD., Osaka, Japan) by
making radial incisions. They were then mounted under a cov-
erslip and observed using the epifluorescence microscope. For
the preparation of retinal cross-sections, fixed eyes were im-
mersed in 20% sucrose for 48 h at 4 °C, and embedded in
optimum cutting temperature (OCT) compound (Sakura
Finetechnical Co., Ltd, Tokyo, Japan). Transverse, 10 µm thick
cryostat sections were cut and placed onto slides (MAS COAT)
under a coverslip, and observed using the laser confocal mi-
croscope.
579Immunoblotting:  RGC-5 cells or mouse retinas were ly-
sed using a cell-lysis buffer (RIPA buffer (R0278; Sigma) with
protease (P8340; Sigma Aldrich) and phosphatase inhibitor
cocktails (P2850 and P5726; Sigma), and 1 mM EDTA). Cell
lysates were solubilized in SDS-sample buffer, separated on
10% SDS-polyacrylamide gels, and transferred to PVDF mem-
brane (Immobilon-P; Millipore, Bedford, MA). Transfers were
blocked for 1 h at room temperature with 5% Blocking One-P
(Nakarai Tesque, Inc., Kyoto, Japan) in 10 mM Tris-buffered
saline with 0.05% Tween 20 (TBS-T), then incubated over-
night at 4 °C with the primary antibody. The transfers were
then rinsed with TBS-T and incubated for 1 h at room tem-
perature in horseradish peroxidase goat anti-rabbit or goat anti-
mouse (Pierce, Rockford, IL) diluted 1:2000. The immunoblots
were developed using chemiluminescence (Super Signal®
West Femto Maximum Sensitivity Substrate; Pierce), and vi-
sualized with the aid of a digital imaging system (FAS-1000;
Toyobo CO., LTD, Osaka, Japan). The primary antibodies used
were as follows: mouse anti-BiP (BD Bioscience, San Jose,
CA), rabbit anti-phospho-eIF2α (Ser51; Cell Signaling,
Beverly, MA), rabbit anti-eIF2α (Cell Signaling), mouse anti-
CHOP (Santa Cruz, Santa Cruz, CA), and rabbit anti-actin
(Santa Cruz).
Immunostaining:  To clarify the distribution and localiza-
tion of the XBP1-venus fusion protein in the retina of ERAI
mice (as seen in the retinal flatmounts and cross sections),
double-staining immunocytochemistry was performed. At
various times after intravitreal injections (12, 24, and 72 h),
eyes were enucleated, fixed in 4% paraformaldehyde over-
night at 4 °C, immersed in 20% sucrose for 48 h at 4 °C, and
embedded in optimum cutting temperature (OCT) compound
(Sakura Finetechnical Co., Ltd, Tokyo, Japan). Transverse, 10
µm thick cryostat sections were cut and placed onto slides
MAS COAT (MATSUNAMI GLASS IND., LTD.). Sections
were subsequently processed for immunocytochemical local-
ization using antibodies against CHOP (1:100 dilution in PBS;
Santa Cruz), glucose-regulated protein 78(GRP78)/BiP (1:100
dilution in PBS), thymus cell antigen 1 (Thy-1; 1:100 dilution
in PBS; Serotec Ltd, Oxford UK), microglia (OX-42, 1:100
dilution in PBS; Serotec Ltd), and amacrine cells (HPC-1/
Syntaxin, 1:100 dilution in PBS; Santa Cruz). The sections
were incubated either (a) with Alexa Fluor-568-conjugated
secondary antibody (1:200 dilution in PBS; Molecular Probes,
Eugene, OR) for 1 h at room temperature, mounted with a
coverslip, and observed under a laser confocal microscope
(Bio-Lad Laboratories, Inc), or (b) with biotin-conjugated sec-
ondary antibody for 1 h at room temperature, and visualized
using a VECTOR M.O.M. Immunodetection kit (Vector,
Burlingame, CA). Each image was taken using a digital cam-
era (Coolpix 4500; Nikon, Tokyo, Japan) attached with
epifluorescence microscope (Power BX50; Olympus).
Histological analysis of mouse retina:  Seven days after
the NMDA or tunicamycin injection, eyeballs were enucle-
ated for histological analysis. In mice under anesthesia, pro-
duced by an intraperitoneal injection of sodium pentobarbital
(80 mg/kg), each eye was enucleated, then kept immersed for
at least 24 h at 4 °C in a fixative solution containing 4%
paraformaldehyde. Six paraffin-embedded sections (thickness,
3 µm) cut through the optic disc of each eye were prepared in
a standard manner, and stained with hematoxylin and eosin.
Retinal damage was evaluated as described previously, and
three sections from each eye were used for the morphometric
analysis. Light-microscope photographs were taken using a
digital camera (Coolpix 4500, Nikon) and the cell counts in
the ganglion cell layer (GCL) and the thickness of the inner
plexiform layer (IPL) at a distance between 350 and 650 µm
from the optic disc were measured on the images in a masked
fashion by a single observer (Y.I.). Data from three sections
(selected randomly from the six sections) were averaged for
each eye, and the values obtained were used to evaluate the
GCL cell count and the IPL thickness.
Statistical analysis:    Data are presented as the
means±SEM. Statistical comparisons were made using a
Student’s t-test or Dunnett’s test, by means of STAT VIEW
version 5.0 (SAS Institute Inc., Cary, NC). P<0.05 was con-
sidered to be statistically significance.
RESULTS
Retinal cell death and time-course of changes in endoplasmic
reticulum (ER) stress-related protein induced by tunicamycin:
We examined whether tunicamycin treatment could induce cell
death through ER stress in retinal ganglion cell using RGC-5.
Representative fluorescence stainings of nuclei [using Hoechst
33342, YO-PRO-1, and propidium iodide (PI) dyes] are shown
in Figure 1A. Vehicle-treated control cells displayed normal
nuclear morphology and negative staining with both YO-PRO-
1 dye (which stains early apoptotic and later-stage cells) and
PI dye (which stains late-stage apoptotic cells; upper panels
in Figure 1A). Treatment with tunicamycin led to shrinkage
and condensation of nuclei, and to positive staining with each
of these dyes (lower panels in Figure 1A). The number of cells
exhibiting PI fluorescence was counted, and positive cells were
expressed as the percentage of PI- to Hoechst 33342-positive
cells (Figure 1B). After treatment with tunicamycin at 1, 2, or
4 µg/ml for 24 h, the percentages of PI-positive cells were
8.3±1.2% (n=6), 13.1±0.9% (n=6), and 11.3±0.6% (n=6), re-
spectively, while in the non-treated control group the percent-
age was 0.5±0.2% (n=6). After treatment with tunicamycin at
1, 2, or 4 µg/ml for a longer time period (48 h), the corre-
sponding values were 41.5±3.5% (n=6), 43.7±2.1% (n=6), and
50.7±2.6% (n=6), respectively (1.2±0.4% (n=6) for the non-
treated control group). Time-course data for the changes in
the protein levels of glucose-regulated protein (GRP)78/BiP,
the phosphorylated form of eukaryotic initiation factor 2α
(eIF2α), total eIF2α, and C/EBP-homologous protein (CHOP)
occurring after tunicamycin treatment at 2 µg/ml are shown
in Figure 1C. BiP, a biomarker of ER-stress, increased time-
dependently throughout the 24 h tunicamycin treatment pe-
riod, while actin levels remained unchanged. Treatment with
tunicamycin time-dependently induced eIF2α phosphoryla-
tion, while total eIF2α levels were not changed during the 24
h observation period. CHOP was first detected at 6 h after
addition of tunicamycin and persisted thereafter. These data
indicate that treatment with tunicamycin can induce expres-
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580sions of ER stress-related proteins and subsequent apoptotic
cell death in RGC-5 culture in vitro.
Intravitreal injection of tunicamycin induces retinal cell
death in mice:  To clarify whether tunicamycin would induce
retinal cell death in vivo, we examined the histological changes
in the retina at 7 days after intravitreal injection of tunicamycin.
As shown in Figure 2, intravitreal injection of tunicamycin at
0.1 µg/eye (a low dose) induced a significant loss of cells in
the retinal ganglion cell layer (GCL), but no thinning of the
inner plexiform layer (IPL; versus vehicle-treated retinas). At
a high dose of 1µg/eye, tunicamycin significantly decreased
both the cell count in GCL and the IPL thickness (versus the
non-treated normal retina; Figure 2). On the other hand, no
retinal damage was induced by intravitreal injection of an iden-
tical volume of vehicle (versus the non-treated retina). To-
gether, these findings suggest that tunicamycin at 0.1 µg/eye
(giving an estimated concentration in the vitreous body of ap-
proximately 10 µg/ml) induces retinal ganglion cell death at a
concentration similar to that inducing exhibiting the apoptotic
cell death in RGC-5 in vitro.
Increase in XBP-1-venus fusion protein in the retina in
ER stress-activated indicator (ERAI)-transgenic mice:  To in-
vestigate whether ER stress is induced in the mouse retina
during the early stages of retinal damage in vivo, we used
ERAI-transgenic mice carrying the F-XBP1DDBD-venus ex-
pression gene, which allows effective identification of cells
under ER stress in vivo, as previously described by Iwawaki
et al. [11]. Twenty-four h after intravitreal injection of
tunicamycin at 0.1 µg or of N-methyl-D-aspartate (NMDA)
at 40 nmol, the fluorescence intensity arising from the XBP-
1-venus fusion protein was visualized in the retina of anesthe-
tized animals (using an ophthalmoscope) as shown in Figure
3. Both tunicamycin and NMDA increased the fluorescence
intensity of this protein, while little change in fluorescence
intensity was observed in the control fellow eyes. For further
elucidation of this phenomenon, the distribution and time-
course of changes in the fluorescence intensity derived from
the XBP-1-venus fusion protein were measured in retinal
flatmount and transverse sections, as shown in Figure 4A,C.
In the flatmounts, such stimulations as NMDA, an intraocular
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Figure 1. Retinal cell death and time-course of changes in endoplasmic reticulum (ER)-stress related proteins induced by tunicamycin.  A:
Representative fluorescence microscopy showing nuclear stainings for Hoechst 33342 (blue), YO-PRO-1 (green), and propidium iodide (PI,
red) at 48 h after addition of tunicamycin at 1 µg/ml. B: The number of cells displaying PI fluorescence was counted at two time-points, and
positive cells were expressed as the percentage of PI to Hoechst 33342. Each column represents the mean±SEM (n=6). Double asterisks and
double hash marks; p<0.01 versus corresponding control group (Dunnett’s test). C: Representative immunoblots showing the time-course of
changes in protein levels (GRP78/BiP, phosphorylated-eIF2α, total eIF2α, and CHOP) after tunicamycin treatment at 2 µg/ml.
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Figure 2. Intravitreal injection of tunicamycin induces retinal cell death in mice.  A: Representative photographs showing non-treated normal
retina, vehicle-treated retina, and low-dose (0.1 µg/eye) and high-dose (1 µg/eye) tunicamycin-treated retinas 7 days after intravitreal injec-
tion. Quantitative analysis of cell number in ganglion cell layer (B) and thickness of inner plexiform layer (IPL) C: Each column represents
the mean±SEM (n=10). Double asterisks p<0.01 versus vehicle-treated control group (Dunnett’s test). The horizontal scale bar represents 25
µm and the vertical bar indicates each thickness of IPL.
Figure 3. Non-invasive imaging of XBP-1-venus fusion protein in ERAI mouse retina in vivo.  Twenty-four hours after intravitreal injection
of either tunicamycin at 0.1 µg/eye or N-methyl-D-aspartate (NMDA) at 40 nmol/eye, the fluorescence intensity arising from XBP-1-venus
fusion protein was visualized in the retinas of anesthetized animals using an ophthalmoscope fitted with a fluorescence filter.
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Figure 4. Expression and localization of XBP-1-venus fusion protein in ERAI mouse retinas after various types of retinal damage.  A: Repre-
sentative fluorescence photographs of increased XBP-1-venus fusion protein in ERAI mouse flatmounted retina after N-methyl-D-aspartate
(NMDA), intraocular pressure (IOP) elevation, or tunicamycin insult. The fluorescence (green) arising from XBP-1-venus fusion protein was
observed under an epifluorescence microscope. The scale bar represents 25 µm. B: Distribution of increased XBP-1-venus fusion protein in
retinal cross-sections from ERAI mice after NMDA injection at 40 nmol/eye. The distribution of fluorescence (green) arising from XBP-1-
venus fusion protein was observed under a laser confocal microscope. Each large box shows an enlargement of the area within the correspond-
ing small box. C: Localization of XBP-1-venus fusion protein in ERAI mouse retina after NMDA injection. In the retinal nerve fiber layer
(upper panels), Thy-1-positive cells (red) can be seen to merge with XBP-1-venus fusion protein (green). In the middle panels, OX-42 (a
microglia marker)-positive cells (red) are partly merged with XBP-1-venus fusion protein (green). In the inner plexiform layer (lower panels),
HPC-1 (an amacrine marker)-positive cells (red) are merged with XBP-1-venus fusion protein (green).
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pressure (IOP) elevation, and tunicamycin all induced increases
in fluorescence intensity at the time-points indicated in Fig-
ure 4A. In the NMDA-treated retinas of ERAI mice, the back-
ground fluorescence intensity was time-dependently increased
in the period from 12 to 72 h, but little change was observed
in the NMDA-treated retinas of wild-type mice.
These changes in background could reflect increases in
the lower part of the ganglion cell layer, such as the inner
plexiform layer and neuroepithelial layer, of the retina. In trans-
verse sections, increases in fluorescence intensity were first
observed in cells of the GCL and inner plexiform layer at 12
and 24 h, respectively, after NMDA injection, and the increases
peaked in GCL cells at 24 h (Figure 4B). The increase in fluo-
rescence had diminished at 72 h after the NMDA injection,
but morphologically distinct cells (such as microglia cells) had
appeared in GCL. On the other hand, the retinas of wild-type
and non-treated ERAI mice showed a low fluorescence inten-
sity (below background), while a slight fluorescence intensity
was observed in the neuroepithelial layer of the retina (Figure
4B). These cells merged with Thy-1-positive cells (ganglion
cells) and some OX-42-positive cells (microglia) in GCL, and
with HPC-1-positive cells (amacrine cells) in IPL (Figure 4C).
Together, these results suggest that XBP-1 splicing, represent-
ing activation of the ER-stress signal pathway, may be induced
in retinal ganglion and amacrine and microglia cells during
the early stages of retinal cell damage.
Increases in GRP78/BiP and CHOP in mouse retina af-
ter NMDA injection:  To clarify whether ER stress-related pro-
teins other than XBP-1 are induced in the mouse retina by
NMDA stimulation, we examined the changes in BiP, a
biomarker of ER stress, in the retina after intravitreal injec-
tion of NMDA. As shown in Figure 5B, cell loss in GCL and
thinning of IPL were observed at 72 h after NMDA injection
(versus non-treated control retinas; Figure 5A). Using
immunoblots, as shown in Figure 5C, we found that BiP was
significantly increased at 12 h after the NMDA injection, and
that the increase persisted for the remainder of the 72 h obser-
vation period. Next, we investigated the distribution and time-
course of changes in GRP78/BiP and CHOP, a proapoptosis
protein, after NMDA injection. In the non-treated control
retina, slight immunoreactivities for BiP and CHOP were ob-
served in a number of cells in GCL and IPL (Figure 5D). In-
creases in these immunoreactivities were observed in retinal
ganglion cells at 12 h after NMDA injection, and time-depen-
dent increases were noted in the inner retina (Figure 5D).
DISCUSSION
 In the present study, we could detect pathological changes
and time-dependent changes related to ER stress in retinal
flatmount and transverse sections and in the retinas of living
mice after retinal damage. Moreover, we demonstrated that
ER stress signals were activated in the retina in vivo after
tunicamycin, elevating IOP, or NMDA treatment.
Agents or conditions that adversely affect ER protein fold-
ing lead to an accumulation of unfolded or misfolded proteins
in the ER, a condition defined as ER stress. ER stress can be
induced by agents or conditions that interfere with (a) protein
glycosylation (e.g., glucose starvation, tunicamycin, glu-
cosamine), (b) disulfide-bond formation (e.g., DTT, homocys-
teine), (c) Ca2+ balance (A23187, thapsigargin, EGTA), and/
or (d) a general overloading of the ER with proteins (e.g., vi-
ral or non-viral oncogenesis) [1,13,14]. However, little is
known about any involvement of ER stress in retinal damage.
In the present study, we found that tunicamycin induced the
ER stress-associated proteins BiP, p-eIF2α, and CHOP in cul-
tured RGC-5 cells. These protein levels started to increase at
2 to 6 h after the start of tunicamycin treatment, and increased
time-dependently until 24 h after the start of the treatment,
while apoptotic cell death with condensation and fragmenta-
tion of nuclei was observed 24 h later. BiP acts as an ER resi-
dent molecular chaperon that is induced by ER stress, and this
protein refolds the unfolded proteins, thereby tending to main-
tain homeostasis in the ER [15,16]. Since CHOP is a member
of the CCAAT/enhancer-binding protein family that is induced
by ER stress and participates in ER-mediated apoptosis, CHOP
may be a key molecule in retinal cell death [17]. In the present
study, the phosphorylation of eIF2α was increased concomi-
tantly with the increases in the expression of BiP and CHOP
proteins, even through p-eIF2α might be expected to suppress
protein synthesis. Boyce et al.[18] reported that selective in-
hibition of eIF2α dephosphorylation increases both p-eIF2α
and CHOP protein. These data suggest that during ER stress,
p-eIF2α (inactive form) is still able to stimulate the transla-
tion of ATF4 mRNA, thereby increasing the transcription of
BiP or CHOP mRNA, but that enough unphosphorylated-
eIF2α (active form) may remain to translate BiP and CHOP
mRNAs to proteins. On the other hand, we found that
staurosporine, which mediates mitochondrial dysfunctions
resulting in apoptotic cell death, did not induce any increases
in BiP and CHOP proteins in RGC-5 [unpublished data]. Taken
together, these findings suggest that persistent ER stress may
induce apoptotic cell death through the eIF2α-CHOP signal
pathway in RGC-5.
Next, we tried to determine whether tunicamycin could
induce retinal damage in vivo. Intravitreal injection of low-
dose tunicamycin induced a significant loss of cells in the reti-
nal ganglion cell layer (GCL), but no thinning of the inner
plexiform layer (IPL). These findings suggest that retinal gan-
glion cells are more sensitive to ER stress-induced cell death
than other retinal cells. High-dose tunicamycin significantly
decreased both the cell count in GCL and the thickness of
IPL. The concentration of tunicamycin in the vitreous body
after an intravitreal injection of low-dose tunicamycin was es-
timated to be 10 µg/ml. The tunicamycin concentration
achieved within the retina will have been less than this. Inter-
estingly, in the present in vitro study, tunicamycin at 1 to 4
µg/ml induced cell death with an increase in ER-stress sig-
nals, suggesting that the in vivo concentration of tunicamycin
in the retina was roughly similar to that employed in vitro.
Use of tunicamycin at a high dose also led to decreases in
IPL, INL (inner nuclear layer), and ONL (outer nuclear layer)
in the retina. In guinea pigs, a single subcutaneous injection
of tunicamycin at 0.4 mg/kg has been reported to induce hepa-
totoxicity with dilation of the cisternae of the ER [19]. Fur-
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Figure 5. Increases in GRP78/BiP and CHOP in retinal extracts following stimulation by intravitreal injection of N-methyl-D-aspartate (NMDA)
in mice.  A, B: Representative photographs showing retinal cross-sections stained with hematoxylin and eosin after NMDA injection at 40
nmol/eye. C, upper panel: Representative immunoblots showing the time-course of changes in GRP78/BiP protein levels after intravitreal
injection of NMDA. C, lower panel: Quantitative analysis of GRP78/BiP band densities. Data are expressed as mean±SEM (n=6) of values (in
arbitrary units) obtained for single band density. Double asterisks represents p<0.01 versus vehicle-treated control group (Dunnett’s test). D:
Immunostainings for GRP78/BiP and CHOP in mouse retina after NMDA injection at 40 nmol. The scale bar represents 25 µm.
585thermore, Zinszner et al.[20] noted that in mice, a single sub-
lethal intraperitoneal injection of tunicamycin (1 mg/kg) in-
duces CHOP expression and subsequent severe histological
damage with an increase in TUNEL-positive cells, and a char-
acteristic transient renal insufficiency. They also found that
CHOP-deficient mice show an attenuated increase in TdT-
mediated dUTP nick-end labeling (TUNEL)-positive cells
during the renal damage induced by tunicamycin. These find-
ings suggest that in vivo, tunicamycin-induced retinal cell death
is due, at least in part, to an ER-stress mechanism.
NMDA receptors may participate in the processes of
excitotoxicity and neuronal death in the retina [21,22]. Previ-
ous studies have found that TUNEL-positive cells can be ob-
served in the GCL and INL of the mouse retina at an early
stage (within 24 h) after an intravitreal injection of NMDA
[23,24]. The hallmark of NMDA-induced neuronal death is a
sustained increase in the intracellular Ca2+ concentration ac-
companied by overactivation of vital Ca2+-dependent cellular
enzymes [25]. Thus, the signal-transduction pathways for
NMDA-mediated cell death in the retina are well studied, but
not yet fully understood.
To illuminate the role and distribution of ER stress in vivo,
we focused on the retina of ERAI mice. Information about the
status of ER stress during the course of a given disease might
be obtained by crossing an ERAI transgenic mouse (the indi-
cator mouse for ER stress in living cells) with a mouse model
of the human disease of interest. In flatmounted retinas, fluo-
rescence was detected following various stimulations
[tunicamycin, NMDA, and intraocular pressure (IOP) eleva-
tion]. To our knowledge, this is the first report demonstrating
that NMDA and ischemic insult (elevating IOP), in addition
to tunicamycin, can activate the ER stress signal (measured as
the splicing of the XBP-1 and venus fusion gene in ERAI
transgenic mice) in the retina in vivo. Interestingly, ER stress
was also induced in the retina after a transient IOP elevation,
defined as an ischemia-reperfusion model. It has been reported
that this model exhibits retinal cell damage similar to that in-
duced by NMDA, and that both of these examples of damage
are protected against by MK-801, an NMDA receptor antago-
nist, and by NO synthetase-inhibitor treatment [8,26]. Although
little is known about the precise mechanisms responsible for
activation of ER stress after NMDA or IOP elevation (is-
chemia-reperfusion), both stimuli cause intracellular Ca2+ over-
load and increased NO production, resulting in apoptotic cell
death. Several lines of study suggest that intracellular Ca2+
overload and excessive production of NO deplete Ca2+ in the
ER, thereby resulting in ER stress [27,28]. Recently, Uehara
et al.[10] reported that NO induces S-nitrosylation of protein-
disulphide isomerase (PDI), an enzyme that assists in the matu-
ration and transport of unfolded secretory proteins and thereby
helps to prevent the neurotoxicity associated with ER stress.
S-nitrosylated-PDI exhibits reduced enzymatic activity and
induces cell death through the ER stress pathway. These mecha-
nisms may contribute to the activation of ER stress in the retina
after NMDA stimulation or IOP elevation. Accordingly, our
findings may provide important new insights into the mecha-
nisms underlying the retinal cell damage induced by NMDA
and by ischemia-reperfusion. In transverse retinal sections, we
observed an increase in fluorescence intensity within the cells
of the ganglion cell layer (GCL) and inner plexiform layer
(IPL) at 12 and 24 h, respectively, after NMDA injection. The
cells displaying increased fluorescence were ganglion cells
(at 12 h after the injection), amacrine cells in IPL (at 24 h),
and microglia in GCL (at 72 h). These data indicate that gan-
glion cells may be more sensitive to ER stress than the other
retinal cells examined.
To further clarify the participation of ER stress, we ex-
amined the changes in BiP and CHOP in the retina after
NMDA-induced injury. We found (a) that NMDA induced BiP
proteins in the retina at 12 h after its injection (on the basis of
immunoblots), and (b) that, NMDA induced both BiP and
CHOP in the retina (especially within retinal ganglion cells
and INL) at 12 h after its injection (on the basis of our
immunostaining results). The expression of the CHOP gene
reportedly increases in the rat retina after intravitreal injec-
tion of NMDA [29]. Furthermore, Awai et al.[30] found that
treatment with MK-801, an NMDA receptor antagonist, in-
hibited the increases in CHOP mRNA and protein in the mouse
retina that are observed after intravitreal injection of NMDA,
and moreover that CHOP-deficient mice were resistant to
NMDA-induced retinal damage. However, CHOP-deficient
mice partially suppressed the NMDA-induced cell death, and
therefore other pathways, such as mitochondrial dysfunction,
may be engaged in the retinal cell death. Collectively, the above
results indicate that NMDA can cause ER stress in the retina,
and that the neurotoxicity induced by NMDA is due in part to
a mechanism dependent on CHOP protein induction through
excessive ER stress.
In conclusion, we have identified a close association be-
tween ER stress and retinal damage, and our results suggest
that the ER stress-signal pathway might be a good target in
the treatment of retinal diseases.
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